Search research articles
Contact Us
Filters
Showing results (31-40 of 35) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 35 results.
The Canadian Journal of Cardiology
|
December 17, 1998
The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE Investigators
S S Anand, S Yusuf, V Vuksan, et al.
Journal of Internal Medicine
|
November 29, 2014
Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies
M Böhm, H Schumacher, R E Schmieder, et al.
Diabetes Care
|
February 13, 2008
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
, G R Dagenais, H C Gerstein, et al.
QJM : Monthly Journal of the Association of Physicians
|
September 12, 2007
Venous thromboembolism in association with features of the metabolic syndrome
J G Ray, E Lonn, Q Yi, et al.
The American Journal of Cardiology
|
November 6, 2001
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data
V J Dzau, K Bernstein, D Celermajer, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 35) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 35 results.
The Canadian Journal of Cardiology
|
December 17, 1998
The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE Investigators
S S Anand, S Yusuf, V Vuksan, et al.
Journal of Internal Medicine
|
November 29, 2014
Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies
M Böhm, H Schumacher, R E Schmieder, et al.
Diabetes Care
|
February 13, 2008
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
, G R Dagenais, H C Gerstein, et al.
QJM : Monthly Journal of the Association of Physicians
|
September 12, 2007
Venous thromboembolism in association with features of the metabolic syndrome
J G Ray, E Lonn, Q Yi, et al.
The American Journal of Cardiology
|
November 6, 2001
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data
V J Dzau, K Bernstein, D Celermajer, et al.
Page
of 4